EXPLEO SOLUTIONS Latest Share Price (EXPLEOSOL)
TODAY IN ONE LINE
EXPLEOSOL edged up 0.6% on light volume, in line with Nifty's -0.3% move.
With a market cap of ₹1,383.43 Cr., it trades at a P/E of 10.02. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
EXPLEO SOLUTIONS flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 73.2% YoY
- ●High Capital EfficiencyROCE of 32.0% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 16.0%
- ●Reasonable ValuationTrading at a moderate P/E of 10.0x
- ●High Promoter HoldingPromoters hold 71.0% skin-in-the-game
- ●Steady Dividend YieldReliable 12.34% dividend yield
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Sales ContractionQuarterly sales dropped 12.3% YoY
Latest EXPLEO SOLUTIONS News
What changed recently?
Recent events, corporate actions, and announcements.
EXPLEO SOLUTIONS valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for EXPLEO SOLUTIONS, framed against the sector median so the premium or discount is obvious at a glance.
EXPLEO SOLUTIONS trades at a P/E of 10.02× and P/B of 1.78×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
EXPLEO SOLUTIONS technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for EXPLEO SOLUTIONS — derived from the latest tape, not yesterday's close.
EXPLEO SOLUTIONS last traded at ₹889.5 with an intraday range of ₹873.2–₹892.95 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹889.50| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 936.73 | +47.23 | +5.31% |
| R3 | 916.98 | +27.48 | +3.09% |
| R2 | 904.97 | +15.47 | +1.74% |
| R1 | 897.23 | +7.73 | +0.87% |
| PIVOT | 885.22 | -4.28 | -0.48% |
| CURRENT | 889.50 | — | — |
| S1 | 877.48 | -12.02 | -1.35% |
| S2 | 865.47 | -24.03 | -2.70% |
| S3 | 857.73 | -31.77 | -3.57% |
| S4 | 837.98 | -51.52 | -5.79% |
EXPLEOSOL is trading Above CPR, indicating Bullishness
CPR is Average
Day's range: ₹873.2–₹884.15
Trading Inside opening range
EXPLEO SOLUTIONS financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for EXPLEO SOLUTIONS — consolidated or standalone — with margins, YoY growth and key ratios inline.
EXPLEO SOLUTIONS reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹1,383.43 Cr. and reported EPS of ₹18.78.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 1,025 | 1,108 ▲ 8.1% |
| Sales Growth YoY %Derived | 6.21% | 8.12% |
| Other Income | 16 | 38 ▲ 133.8% |
| Total Income | 1,041 | 1,146 ▲ 10.1% |
| 7 | 15 ▲ 93.9% | |
| Gross ProfitDerived | 1,017 | 1,093 ▲ 7.5% |
| Gross Margin %Derived | 99.27% | 98.69% |
| 852 | 923 ▲ 8.4% | |
| EBITDA (Operating Profit)Derived | 166 | 170 ▲ 2.6% |
| OPM %Derived | 16.17% | 15.34% |
| 43 | 16 ▼ 62.9% | |
| Profit Before Tax (PBT) | 139 | 163 ▲ 16.8% |
| 36 | 39 ▲ 7.2% | |
| Effective Tax %Derived | 25.85% | 23.73% |
| Total Profit for Period | 103 | 124 ▲ 20.1% |
| Net Profit (Owner's PAT)Derived | 103 | 124 ▲ 20.1% |
| Net Profit Margin %Derived | 10.07% | 11.19% |
| PAT Growth YoY %Derived | 14.16% | 20.09% |
| Earnings Per Share (EPS ₹) | 66.52 | 79.89 ▲ 20.1% |
| Diluted Shares Outstanding (Cr) | 2 | 2 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | -1 | 16 ▲ 1833.5% |
| Total Expenses (incl. D&A & Interest) | 902 | 983 ▲ 9.0% |
| Material Cost % of RevenueDerived | 0.73% | 1.31% |
| Employee Cost % of RevenueDerived | 59.31% | 62.29% |
| Other Cost % of RevenueDerived | 23.79% | 21.06% |
| Interest Coverage (x)Derived | 38.04x | 63.37x |
| Period | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 276 | 283 ▲ 2.3% | 269 ▼ 4.7% | 301 ▲ 11.7% | 405 ▲ 34.4% | 903 ▲ 123.3% | 965 ▲ 6.8% | 1,025 ▲ 6.2% | 1,108 ▲ 8.1% | |
| Sales Growth YoY %Derived | — | 2.29% | -4.73% | 11.69% | 34.44% | 123.31% | 6.82% | 6.21% | 8.12% | |
| Other Income | 8 | 6 ▼ 25.6% | 9 ▲ 43.1% | 5 ▼ 36.9% | 4 ▼ 34.3% | 16 ▲ 352.4% | 8 ▼ 53.4% | 16 ▲ 115.7% | 38 ▲ 133.8% | |
| Total Income | 284 | 289 ▲ 1.5% | 278 ▼ 3.7% | 306 ▲ 10.2% | 408 ▲ 33.2% | 919 ▲ 125.3% | 972 ▲ 5.8% | 1,041 ▲ 7.1% | 1,146 ▲ 10.1% | |
— | — | — | — | — | 7 | 5 ▼ 31.9% | 7 ▲ 50.1% | 15 ▲ 93.9% | ||
| Gross ProfitDerived | 276 | 283 ▲ 2.3% | 269 ▼ 4.7% | 301 ▲ 11.7% | 405 ▲ 34.4% | 896 ▲ 121.5% | 960 ▲ 7.1% | 1,017 ▲ 6.0% | 1,093 ▲ 7.5% | |
| Gross Margin %Derived | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 99.19% | 99.48% | 99.27% | 98.69% | |
231 | 230 ▼ 0.5% | 217 ▼ 5.5% | 231 ▲ 6.5% | 327 ▲ 41.6% | 696 ▲ 112.6% | 812 ▲ 16.6% | 852 ▲ 4.9% | 923 ▲ 8.4% | ||
| EBITDA (Operating Profit)Derived | 46 | 53 ▲ 16.3% | 52 ▼ 1.4% | 70 ▲ 33.3% | 77 ▲ 10.6% | 200 ▲ 159.0% | 148 ▼ 25.9% | 166 ▲ 11.7% | 170 ▲ 2.6% | |
| OPM %Derived | 16.53% | 18.79% | 19.45% | 23.21% | 19.10% | 22.16% | 15.37% | 16.17% | 15.34% | |
6 | 6 ▼ 4.6% | 7 ▲ 24.5% | 7 ▼ 1.0% | 9 ▲ 26.7% | 30 ▲ 246.7% | 36 ▲ 20.4% | 43 ▲ 17.5% | 16 ▼ 62.9% | ||
| Profit Before Tax (PBT) | 48 | 54 ▲ 11.8% | 54 ▲ 0.9% | 68 ▲ 26.5% | 72 ▲ 5.5% | 186 ▲ 158.0% | 120 ▼ 35.7% | 139 ▲ 16.4% | 163 ▲ 16.8% | |
16 | 17 ▲ 9.0% | 14 ▼ 18.5% | 18 ▲ 26.9% | 18 ▲ 1.5% | 52 ▲ 186.3% | 29 ▼ 44.2% | 36 ▲ 23.6% | 39 ▲ 7.2% | ||
| Effective Tax %Derived | 33.27% | 32.42% | 26.18% | 26.26% | 25.28% | 28.06% | 24.37% | 25.85% | 23.73% | |
| Total Profit for Period | 32 | 36 ▲ 13.2% | 40 ▲ 10.2% | 50 ▲ 26.4% | 54 ▲ 6.9% | 134 ▲ 148.4% | 90 ▼ 32.5% | 103 ▲ 14.2% | 124 ▲ 20.1% | |
| Net Profit (Owner's PAT)Derived | 32 | 36 ▲ 13.2% | 40 ▲ 10.2% | 50 ▲ 26.4% | 54 ▲ 6.9% | 134 ▲ 148.4% | 90 ▼ 32.5% | 103 ▲ 14.2% | 124 ▲ 20.1% | |
| Net Profit Margin %Derived | 11.57% | 12.80% | 14.81% | 16.76% | 13.33% | 14.82% | 9.37% | 10.07% | 11.19% | |
| PAT Growth YoY %Derived | — | 13.22% | 10.22% | 26.41% | 6.87% | 148.38% | -32.45% | 14.16% | 20.09% | |
| Earnings Per Share (EPS ₹) | 29.78 | 33.79 ▲ 13.5% | 38.92 ▲ 15.2% | 49.20 ▲ 26.4% | 52.58 ▲ 6.9% | 130.59 ▲ 148.4% | 58.27 ▼ 55.4% | 66.52 ▲ 14.2% | 79.89 ▲ 20.1% | |
| Diluted Shares Outstanding (Cr) | 1 | 1 ▲ 0.0% | 1 ▼ 4.3% | 1 ▲ 0.0% | 1 ▲ 0.0% | 1 ▲ 0.0% | 2 ▲ 51.4% | 2 ▲ 0.0% | 2 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | -0 | -0 ▼ 101.3% | -0 ▼ 179.4% | -1 ▼ 80.1% | -1 ▲ 27.1% | 2 ▲ 410.4% | -2 ▼ 199.7% | -1 ▲ 46.0% | 16 ▲ 1833.5% | |
| Total Expenses (incl. D&A & Interest) | 237 | 235 ▼ 0.6% | 224 ▼ 4.8% | 238 ▲ 6.2% | 336 ▲ 41.2% | 733 ▲ 118.3% | 853 ▲ 16.3% | 902 ▲ 5.7% | 983 ▲ 9.0% | |
| Material Cost % of RevenueDerived | — | — | — | — | — | 0.81% | 0.52% | 0.73% | 1.31% | |
| Employee Cost % of RevenueDerived | 66.60% | 64.84% | 66.56% | 52.21% | 48.17% | 53.13% | 59.58% | 59.31% | 62.29% | |
| Other Cost % of RevenueDerived | 16.87% | 16.37% | 13.99% | 24.58% | 32.73% | 23.91% | 24.53% | 23.79% | 21.06% | |
| Interest Coverage (x)Derived | 139.86x | 711.03x | 42.04x | 60.65x | 91.36x | 76.35x | 43.95x | 38.04x | 63.37x |
EXPLEO SOLUTIONS segment analysis : revenue and profit mix.
Disclosed business segments at EXPLEO SOLUTIONS with their share of revenue and profit, switchable between consolidated and standalone reporting.
EXPLEO SOLUTIONS discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for EXPLEO SOLUTIONS.
Our AI distills the core fundamental drivers supporting EXPLEO SOLUTIONS, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
EXPLEO SOLUTIONS's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Strong promoter holding 71.05% signals long-term commitment and strategic stability.
P/E ratio 10.01x significantly below sector median 28.7x, attractive valuation entry.
ROCE 31.76% exceeds peer median ~18%, demonstrating superior capital efficiency.
Minimal leverage with debt-to-equity 0.0000x, fortress-like balance sheet structure.
Dividend yield 12.24% exceeds sector average 3.46%, strong income appeal for investors.
Key Risks.
Latest quarterly PAT declined 14.75% YoY, profitability headwind evident despite TTM strength.
Quarterly sales growth declined 12.31% YoY, significant revenue contraction signal.
Institutional holdings negligible at 0.07%, weak market participation and liquidity.
Operating margin 12.78% TTM modest versus top-tier IT services peers.
Stock trading below 52-week high of 1175.10, limited near-term price momentum.
Flip Conditions.
Valuation risk. a P/E above 13 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Return-quality risk. ROE below 11% would indicate weaker capital compounding.
Income thesis breaks if the dividend is cut or yield falls below 6.17%.
EXPLEO SOLUTIONS peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — EXPLEO SOLUTIONS is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
EXPLEO SOLUTIONS chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for EXPLEO SOLUTIONS — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
EXPLEO SOLUTIONS delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for EXPLEO SOLUTIONS over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in EXPLEO SOLUTIONS stood at 59.1% of traded volume, against a 20-day average of 46.8%.
EXPLEO SOLUTIONS announcements: results, concalls, ratings, M&A.
Filings EXPLEO SOLUTIONS sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
EXPLEO SOLUTIONS files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 85 documents below.
Spurt in Volume
Significant increase in volume has been observed in Expleo Solutions Limited. The Exchange, in order to ensure that investors have latest relevant…
Spurt in Volume
Significant increase in volume has been observed in Expleo Solutions Limited. The Exchange, in order to ensure that investors have latest relevant…
Shareholders meeting
Expleo Solutions Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 26, 2026. Further, the…
Shareholders meeting
Expleo Solutions Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 26, 2026
Resignation of Director/KMP/SMP
Expleo Solutions Limited has informed the Exchange about Resignation of Director/KMP/SMP
Investor decks & rating reports.
EXPLEO SOLUTIONS dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue EXPLEO SOLUTIONS has declared, sequenced by announce and record date.
EXPLEO SOLUTIONS corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About EXPLEO SOLUTIONS: business, sector, key facts.
What EXPLEO SOLUTIONS does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
EXPLEO SOLUTIONS operates in the IT Enabled Services industry under the Information Technology sector, listed as NSE: EXPLEOSOL, BSE: 533121.
Expleo Solutions Limited, headquartered in Chennai, India, is a global provider of software validation and verification services, primarily serving the banking, financial services, and insurance (BFSI) sectors. The company's core business revolves around ensuring the quality and reliability of software applications used within these industries. This involves a comprehensive suite of services designed to mitigate risk and ensure compliance with industry regulations.
Their service offerings are wide-ranging and encompass the entire software lifecycle. This includes initial software development, rigorous testing and quality assurance procedures, and ongoing maintenance and support. Specific services mentioned include computer programming, consultancy, quality management, software testing, digital transformation, product and process engineering, and customer support. These services are tailored to meet the specific needs of clients within the BFSI sector, demonstrating a deep understanding of the unique challenges and regulatory requirements of this industry.
Expleo Solutions' expertise lies in helping BFSI clients navigate the complexities of modern software development and deployment. Their services are aimed at improving efficiency, reducing operational costs, and minimizing the risk of software failures or security breaches. The company’s emphasis on quality and regulatory compliance makes it a valuable partner for organizations operating in the highly regulated BFSI landscape. This strong focus on quality assurance and validation distinguishes them in a competitive market.
The company's history traces back to 1998, operating initially under the name SQS India BFSI Limited before rebranding to Expleo Solutions Limited in April 2019. This rebranding reflects a broader strategic alignment with its parent company, Expleo Technology Germany GmbH, a larger global player in technology services. The company's continued growth and success are indicative of the strong demand for specialized software testing and validation services within the ever-evolving BFSI industry.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- ADROIT INFOTECH (ADROITINFO) Share PricePeer
- ALLIED DIGITAL SERV (ADSL) Share PricePeer
- AFFLE 3I (AFFLE) Share PricePeer
- AIRAN (AIRAN) Share PricePeer
- ASMS (ASMS) Share PricePeer
- Other undervalued NSE stocksScreener
- Quality + Value Portfolio strategyStrategy
- Top quality scorecard stocksScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about EXPLEO SOLUTIONS (EXPLEOSOL).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of EXPLEO SOLUTIONS (EXPLEOSOL)?
The current share price of EXPLEO SOLUTIONS (EXPLEOSOL) is ₹889.50. Today, the stock has gained by ₹5.70 (0.64%), trading in a range of ₹873.20 to ₹892.95. The stock opened at ₹883.00 with a trading volume of 9,546 shares.
02Is EXPLEO SOLUTIONS stock a good investment for long-term?
EXPLEO SOLUTIONS can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,383.43 Cr., P/E ratio of 10.02, ROE of 15.97%, and ROCE of 31.98%. The dividend yield stands at 12.34%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of EXPLEO SOLUTIONS stock?
The 52-week high price of EXPLEO SOLUTIONS (EXPLEOSOL) is ₹1,175.10, while the 52-week low is ₹640.00. Currently trading at ₹889.50, the stock is 38.98% above its 52-week low and 24.3% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy EXPLEO SOLUTIONS stock at the current price?
Whether to buy EXPLEO SOLUTIONS stock at ₹889.50 depends on multiple factors. The stock is currently trading with a P/E ratio of 10.02 and P/B ratio of 1.78. Today's performance shows a gain of 0.64%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of EXPLEO SOLUTIONS and when is the next dividend?
EXPLEO SOLUTIONS offers a dividend yield of 12.34%, which means for every ₹100 invested at the current price of ₹889.50, you can expect to receive approximately ₹12.34 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of EXPLEO SOLUTIONS?
EXPLEO SOLUTIONS's key financial metrics include: P/E Ratio: 10.02, P/B Ratio: 1.78, ROE: 15.97%, ROCE: 31.98%, Dividend Yield: 12.34%, EPS: ₹18.78, Book Value: ₹500.21, and Debt-to-Equity: 0. The company's market cap stands at ₹1,383.43 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is EXPLEO SOLUTIONS stock performing today in the market?
EXPLEO SOLUTIONS stock opened at ₹883.00 and is currently trading at ₹889.50, showing a gain of ₹5.70 (0.64%). The intraday high is ₹892.95 and low is ₹873.20. The trading volume stands at 9,546 shares, indicating moderate market participation today.
08What is the P/E ratio of EXPLEO SOLUTIONS and what does it indicate?
EXPLEO SOLUTIONS has a Price-to-Earnings (P/E) ratio of 10.02, which means investors are willing to pay 10.02 for every ₹1 of earnings. With an EPS of ₹18.78, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about EXPLEO SOLUTIONS (EXPLEOSOL) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.